Author: Dr Clemens

Uncategorized Published - 7 December, 2020    By - Dr Clemens
Nerve Blocks for Acute Pain Management

Author: Tony Mira Summary CPT codes often take time to be established.  Many new nerve blocks are still unlisted, even though they are now used quite commonly.  Providers should not be discouraged from trying new techniques just because they may be unpayable.  The process of establishing new codes may be slow, but it does eventually […]

Read More
Uncategorized Published - 7 December, 2020    By - Dr Clemens
Study identifies risk factors of liver injury in patients with COVID-19

This is important in anesthesia due to the drugs we use are often metabolized by the liver. DG Alert Age over 50 years, male sex and use of lopinavir-ritonavir were the independent risk factors of liver injury in coronavirus disease 2019 (COVID-19) patients, according to a study published in the Journal of Medical Virology. Jian Wang, […]

Read More
Uncategorized Published - 7 December, 2020    By - Dr Clemens
Obese COVID-19 patients face a greater risk of in-hospital death, mechanical ventilation

Author: Michael Walter Cardiovascular Business News Obese individuals are more likely to be hospitalized for COVID-19, according to new findings published in Circulation. Obesity was also linked to higher rates of in-hospital mortality and mechanical ventilation. The analysis included data from the American Heart Association’s COVID-19 Cardiovascular Disease Registry. More than 7,500 patients from 88 different U.S. […]

Read More
Uncategorized Published - 4 December, 2020    By - Dr Clemens
Effects of prophylactic atropine on the time to tracheal intubation with the pre-administration of remifentanil

DG Journal Club AUTHORS Jae-Geum Shim, Eun A Cho et al. Acta Anaesthesiol Scand. 2020 Nov 9 BACKGROUND Pre-administration of remifentanil in target-controlled propofol and remifentanil anaesthesia could prolong the time of onset of muscle relaxation owing to haemodynamic effects, thereby prolonging the time to tracheal intubation. Although the sympatholytic effects of remifentanil result in […]

Read More
Uncategorized Published - 4 December, 2020    By - Dr Clemens
Patient and procedural risk factors for increased postoperative pain after cesarean delivery under neuraxial anesthesia

AUTHORS: J E Mehdiratta, R Saab et al. Int J Obstet Anesth. 2020 11; 44 60-67 BACKGROUND There is significant interindividual variability in pain experienced after cesarean delivery. The goal of this study was to identify risk factors for increased postoperative pain in women undergoing cesarean delivery under neuraxial anesthesia with neuraxial morphine. METHODS A […]

Read More
Uncategorized Published - 4 December, 2020    By - Dr Clemens
CDC report: 9% of COVID-19 patients readmitted to same hospital within 2 months

DG Alerts The US Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report has found that 9% of patients discharged from an initial coronavirus disease 2019 (COVID-19) hospitalization were readmitted to the same hospital within 2 months of discharge. In addition, multiple readmissions occurred in 1.6% of patients. Using electronic health record […]

Read More
Uncategorized Published - 4 December, 2020    By - Dr Clemens
Effect of a stepwise opioid-sparing analgesic protocol on in-hospital oxycodone use and discharge prescription after cesarean delivery

DG Journal Club AUTHORS Ruth Landau, Erik Romanelli et al. Reg Anesth Pain Med. 2020 Nov 10 INTRODUCTION Opioid exposure during hospitalization for cesarean delivery increases the risk of new persistent opioid use. We studied the effectiveness of stepwise multimodal opioid-sparing analgesia in reducing oxycodone use during cesarean delivery hospitalization and prescriptions at discharge. METHODS […]

Read More
Uncategorized Published - 4 December, 2020    By - Dr Clemens
Presence of Pneumocystis jirovecii in critically ill patients with COVID-19

DG Alerts An unexpectedly high proportion of Pneumocystis jirovecii-positive pulmonary samples was observed in critically ill coronavirus disease 2019 (COVID-19) patients, according to a study published in Journal of Infection. “Based on our findings, we advocate systematically searching for P. jirovecii in deep respiratory specimens in these patients. We believe that this strategy may be useful in limiting enhanced […]

Read More
Uncategorized Published - 3 December, 2020    By - Dr Clemens
Intranasal oxytocin as a treatment for chronic pelvic pain

This is for our readers who treat pain patients AUTHORS: Michelle J Flynn, Tavis S Campbell et al. Int J Gynaecol Obstet. 2020 Oct 28 OBJECTIVES To investigate the effect of intranasal oxytocin on chronic pelvic pain in a randomized, double-blind, within-subject crossover trial. Aims included: (1) determine intranasal oxytocin’s effect on pain intensity and […]

Read More
Uncategorized Published - 3 December, 2020    By - Dr Clemens
TRPV1-Targeted Drugs in Development for Human Pain Conditions

DG Journal Club AUTHORS Mircea Iftinca, Manon Defaye et al. Drugs. 2020 Nov 9 The transient receptor potential vanilloid-1 (TRPV1) is a non-specific cation channel known for its sensitivity to pungent vanilloid compound (i.e. capsaicin) and noxious stimuli, including heat, low pH or inflammatory mediators. TRPV1 is found in the somatosensory system, particularly primary afferent […]

Read More